Delivery Order SPE2DB22D1106-SPE2DB25FFCC0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100-count units) with a ceiling value of $1,278.13. This competitively awarded, firm fixed-price delivery order is set to be completed by July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100-count units) under a firm fixed-price contract. The award, issued on August 5, 2025, carries a ceiling value of $12,115.04 and requires completion by August 6, 2025. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,883.72 for Lisdexamfetamine 30 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under the company's broader pharmaceutical supply arrangements with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lisdexamfetamine 70 mg capsules (100 count) valued at $1,426.80. The contract is a firm fixed-price delivery order with a completion date of August 8, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This order will be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count) with a ceiling value of $2,031.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine capsules 30mg, with a ceiling value of $4,474.11. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is due for completion by August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,288.73 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 60 mg capsules (100 count) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $7,519.36 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (90-count units) on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation. As a child contract action, this delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Lisdexamfetamine 60 mg capsules (100-count units) with a contract value of $1,525.84. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. As a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine 50 mg capsules in quantities of 100 units, with a ceiling value of $1,006.89. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCC0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100-count units) with a ceiling value of $4,221.50. This competitively awarded, firm fixed-price delivery order is set to be completed by August 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that serves as the primary mechanism for pharmaceutical procurement across the Defense Health Agency and other federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This particular delivery order for Lisdexamfetamine—a controlled substance used in the treatment of attention-deficit/hyperactivity disorder—reflects the ongoing operational needs of Defense Health Agency medical supply chains and reinforces AmerisourceBergen's role as a preferred supplier for specialty and maintenance medications supporting military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/7/25 |